• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食、食物和补充剂摄入对接受内分泌治疗的乳腺癌患者健康结局影响的当前证据

Current Evidence on the Impact of Diet, Food, and Supplement Intake on Breast Cancer Health Outcomes in Patients Undergoing Endocrine Therapy.

作者信息

Žuža Praštalo Milena, Pokimica Biljana, Arsić Aleksandra, Ilich Jasminka Z, Vučić Vesna

机构信息

Group for Nutritional Biochemistry and Dietology, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.

Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.

出版信息

Nutrients. 2025 Jan 26;17(3):456. doi: 10.3390/nu17030456.

DOI:10.3390/nu17030456
PMID:39940314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11820974/
Abstract

BACKGROUND/OBJECTIVES: The most common type of breast cancer (BRC) in women is estrogen/progesterone receptor positive. First-line treatment includes endocrine therapy, either with aromatase inhibitors or tamoxifen to reduce estrogen levels. Among the side effects produced by this treatment, aromatase inhibitor-induced arthralgia is the most common, affecting the patients' overall health and quality of life (QoL). The objectives here were to evaluate interventions examining the impact of modified diets, supplements, and/or some food components on health outcomes in BRC patients undergoing endocrine therapy.

METHODS

The literature search was performed in PubMed, Scopus, and Web of Science from June 2024, as well as manually, through the end of November 2024. The search was limited to studies of women diagnosed with estrogen/progesterone-receptor-positive BRC with selected articles reporting interventions with diet, food, or supplement intake and examining the relevant health outcomes. Studies not focusing on BRC patients undergoing endocrine therapy or not including specific health outcomes were excluded.

RESULTS

The search uncovered 1028 studies; after the removal of duplicates, abstracts, and irrelevant studies, 53 were closely examined, with 26 evaluated and presented here. The outcomes were changes in bone and body composition, cardiovascular disease risks, inflammation, and QoL.

CONCLUSIONS

The examined evidence suggests that adherence to dietary patterns such as the Mediterranean or a low-fat diet, and a higher intake of fruits and vegetables were beneficial for various outcomes. Additionally, supplementation with some foods/components (dried plum, red clover) contributed to improving/maintaining bone and body composition, especially in overweight/obese patients. Supplementation with vitamin D or omega-3 improved lipid and angiogenic parameters and QoL. Although these results are promising, the effects of each supplement/food cannot be summarized due to the diverse nature of study designs, patients, and supplement dosages. Further studies are needed to explore the effects of specific nutritional interventions (including the newest, like fasting-mimicking diets and whole-grain cereal diets) on various health outcomes in BRC survivors during endocrine therapy, and to derive universal recommendations.

摘要

背景/目的:女性中最常见的乳腺癌类型是雌激素/孕激素受体阳性。一线治疗包括内分泌治疗,使用芳香化酶抑制剂或他莫昔芬来降低雌激素水平。在这种治疗产生的副作用中,芳香化酶抑制剂引起的关节痛最为常见,会影响患者的整体健康和生活质量(QoL)。这里的目的是评估一些干预措施,这些措施研究了改良饮食、补充剂和/或某些食物成分对接受内分泌治疗的乳腺癌患者健康结果的影响。

方法

2024年6月在PubMed、Scopus和Web of Science数据库进行了文献检索,并手动检索至2024年11月底。检索仅限于诊断为雌激素/孕激素受体阳性乳腺癌的女性研究,所选文章报告了饮食、食物或补充剂摄入的干预措施,并研究了相关的健康结果。未聚焦于接受内分泌治疗的乳腺癌患者或未包括特定健康结果的研究被排除。

结果

检索到1028项研究;在去除重复项、摘要和不相关研究后,对53项进行了仔细审查,其中26项进行了评估并在此呈现。结果包括骨骼和身体成分的变化、心血管疾病风险、炎症和生活质量。

结论

所审查的证据表明,坚持地中海或低脂等饮食模式,以及增加水果和蔬菜的摄入量,对各种结果有益。此外,补充一些食物/成分(李子干、红三叶草)有助于改善/维持骨骼和身体成分,尤其是超重/肥胖患者。补充维生素D或ω-3可改善脂质和血管生成参数以及生活质量。尽管这些结果很有前景,但由于研究设计、患者和补充剂剂量的多样性,无法总结每种补充剂/食物的效果。需要进一步研究探索特定营养干预措施(包括最新的,如模拟禁食饮食和全谷物谷物饮食)对内分泌治疗期间乳腺癌幸存者各种健康结果的影响,并得出通用建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0737/11820974/30ab73e94be7/nutrients-17-00456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0737/11820974/30ab73e94be7/nutrients-17-00456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0737/11820974/30ab73e94be7/nutrients-17-00456-g001.jpg

相似文献

1
Current Evidence on the Impact of Diet, Food, and Supplement Intake on Breast Cancer Health Outcomes in Patients Undergoing Endocrine Therapy.饮食、食物和补充剂摄入对接受内分泌治疗的乳腺癌患者健康结局影响的当前证据
Nutrients. 2025 Jan 26;17(3):456. doi: 10.3390/nu17030456.
2
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.他莫昔芬与芳香化酶抑制剂在激素反应性早期乳腺癌辅助治疗中的安全性概况。
Ann Oncol. 2007 Sep;18 Suppl 8:viii26-35. doi: 10.1093/annonc/mdm263.
3
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials.激素敏感型晚期乳腺癌患者内分泌治疗类型与雌激素受体 1 突变发展的相关性:一项随机和非随机试验的系统评价和荟萃分析。
Biochim Biophys Acta Rev Cancer. 2019 Dec;1872(2):188315. doi: 10.1016/j.bbcan.2019.188315. Epub 2019 Oct 21.
4
Aromatase inhibitor-associated arthralgia syndrome.芳香化酶抑制剂相关关节痛综合征
Breast. 2007 Jun;16(3):223-34. doi: 10.1016/j.breast.2007.01.011. Epub 2007 Mar 21.
5
Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy.真实世界评估接受辅助内分泌治疗的乳腺癌患者的生活质量。
Future Oncol. 2022 Jul;18(22):2425-2439. doi: 10.2217/fon-2021-1322. Epub 2022 Jun 13.
6
Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer.辅助内分泌治疗对乳腺癌绝经后妇女口腔健康的潜在影响。
Breast Cancer Res Treat. 2013 Jan;137(1):23-32. doi: 10.1007/s10549-012-2217-z. Epub 2012 Sep 18.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Factors predictive of response to hormone therapy in breast cancer.乳腺癌激素治疗反应的预测因素。
Tumori. 2008 May-Jun;94(3):370-83. doi: 10.1177/030089160809400314.
9
Adjuvant endocrine therapy for postmenopausal women: Type and duration.绝经后女性的辅助内分泌治疗:类型与疗程。
Breast. 2015 Nov;24 Suppl 2:S126-8. doi: 10.1016/j.breast.2015.07.028. Epub 2015 Aug 14.
10
Menopausal symptoms in breast cancer survivors on adjuvant endocrine therapy compared with those of menopausal women.接受辅助内分泌治疗的乳腺癌幸存者与绝经女性的更年期症状比较。
Maturitas. 2025 Jan;191:108143. doi: 10.1016/j.maturitas.2024.108143. Epub 2024 Oct 30.

引用本文的文献

1
The nutritional equation: decoding diet's influence on breast cancer risk and progression - a perspective.营养方程式:解读饮食对乳腺癌风险和进展的影响——一种观点
Ann Med Surg (Lond). 2025 Jul 18;87(9):5528-5534. doi: 10.1097/MS9.0000000000003612. eCollection 2025 Sep.
2
Unlocking the Potential of Bioactive Compounds in Pancreatic Cancer Therapy: A Promising Frontier.挖掘生物活性化合物在胰腺癌治疗中的潜力:一个充满希望的前沿领域。
Biomolecules. 2025 May 15;15(5):725. doi: 10.3390/biom15050725.

本文引用的文献

1
Osteosarcopenic adiposity and its relation to cancer and chronic diseases: Implications for research to delineate mechanisms and improve clinical outcomes.骨少肌性肥胖及其与癌症和慢性疾病的关系:对阐明机制和改善临床结局的研究的启示。
Ageing Res Rev. 2025 Jan;103:102601. doi: 10.1016/j.arr.2024.102601. Epub 2024 Nov 26.
2
Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits.α-硫辛酸:生物学机制与健康益处
Antioxidants (Basel). 2024 Oct 12;13(10):1228. doi: 10.3390/antiox13101228.
3
Unraveling the Omega-3 Puzzle: Navigating Challenges and Innovations for Bone Health and Healthy Aging.
解开 Omega-3 的谜题:探索骨骼健康和健康老龄化的挑战与创新。
Mar Drugs. 2024 Sep 28;22(10):446. doi: 10.3390/md22100446.
4
Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.大豆异黄酮对雌激素活性指标的影响:随机对照试验的系统评价和荟萃分析
Adv Nutr. 2025 Jan;16(1):100327. doi: 10.1016/j.advnut.2024.100327. Epub 2024 Oct 20.
5
Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells.载姜黄素和他莫昔芬的 pH 响应双子表面活性剂纳米粒对乳腺癌细胞的协同作用。
BMC Complement Med Ther. 2024 Sep 20;24(1):337. doi: 10.1186/s12906-024-04631-x.
6
Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer.营养干预与微生物组调节在乳腺癌管理中的作用。
Nutrients. 2024 Aug 10;16(16):2644. doi: 10.3390/nu16162644.
7
Combined influence of nutritional and inflammatory status and breast cancer: findings from the NHANES.营养和炎症状态与乳腺癌的综合影响:来自 NHANES 的研究结果。
BMC Public Health. 2024 Aug 19;24(1):2245. doi: 10.1186/s12889-024-19727-9.
8
Ganoderma Microsporum Immunomodulatory Protein Alleviates Inflammaging and Oxidative Stress in Diabetes-Associated Periodontitis via Nrf2 Signaling Activation: An In Vitro Study.微孢灵芝免疫调节蛋白通过激活Nrf2信号通路减轻糖尿病相关性牙周炎中的炎症衰老和氧化应激:一项体外研究
Antioxidants (Basel). 2024 Jul 8;13(7):817. doi: 10.3390/antiox13070817.
9
International consensus on fasting terminology.禁食术语的国际共识。
Cell Metab. 2024 Aug 6;36(8):1779-1794.e4. doi: 10.1016/j.cmet.2024.06.013. Epub 2024 Jul 25.
10
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence.周期性禁食模拟饮食在癌症治疗中的应用:临床前和临床证据。
Cell Metab. 2024 Aug 6;36(8):1644-1667. doi: 10.1016/j.cmet.2024.06.014. Epub 2024 Jul 25.